PEPPOLONI, Samuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.938
NA - Nord America 12.499
AS - Asia 6.025
SA - Sud America 666
AF - Africa 88
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 40.243
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.392
US - Stati Uniti d'America 12.320
SG - Singapore 2.353
GB - Regno Unito 2.169
CN - Cina 1.848
HK - Hong Kong 813
DE - Germania 714
SE - Svezia 651
FR - Francia 571
BR - Brasile 540
UA - Ucraina 331
RU - Federazione Russa 265
VN - Vietnam 251
TR - Turchia 224
FI - Finlandia 214
KR - Corea 134
BG - Bulgaria 120
MX - Messico 100
IN - India 94
NL - Olanda 81
AT - Austria 79
ID - Indonesia 63
AR - Argentina 62
PL - Polonia 53
CA - Canada 51
RO - Romania 47
BE - Belgio 46
JP - Giappone 39
BD - Bangladesh 38
ZA - Sudafrica 37
IE - Irlanda 36
CH - Svizzera 32
IQ - Iraq 30
ES - Italia 28
LT - Lituania 18
MA - Marocco 18
PT - Portogallo 18
IR - Iran 17
MY - Malesia 17
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 14
AU - Australia 14
EC - Ecuador 12
CO - Colombia 11
DK - Danimarca 10
TH - Thailandia 10
UZ - Uzbekistan 10
VE - Venezuela 10
IL - Israele 9
TW - Taiwan 9
CL - Cile 8
PK - Pakistan 8
PY - Paraguay 8
EU - Europa 7
HN - Honduras 7
KE - Kenya 7
PE - Perù 7
AL - Albania 6
JO - Giordania 6
KG - Kirghizistan 6
NO - Norvegia 6
UY - Uruguay 6
EG - Egitto 5
PA - Panama 5
PH - Filippine 5
AM - Armenia 4
CR - Costa Rica 4
DZ - Algeria 4
MT - Malta 4
NP - Nepal 4
RS - Serbia 4
SM - San Marino 4
SN - Senegal 4
TN - Tunisia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
LV - Lettonia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
BH - Bahrain 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
Totale 40.225
Salva come PNG Salva come JPEG
Città #
Singapore 1.738
Southend 1.564
Santa Clara 1.384
Ashburn 943
Fairfield 855
Hong Kong 812
Chandler 781
Woodbridge 644
Hefei 631
Milan 626
Jacksonville 600
Rome 589
Houston 511
Bologna 450
Dearborn 446
Ann Arbor 444
Wilmington 347
Nyköping 335
Seattle 317
Beijing 307
Torino 290
San Jose 289
Chicago 277
London 276
Los Angeles 257
Cambridge 229
Florence 227
Modena 227
New York 169
Catania 146
Seoul 127
Genova 125
Council Bluffs 118
Padova 118
Princeton 118
Verona 117
Sofia 116
Izmir 114
Salt Lake City 109
Dallas 108
The Dalles 106
Castelnuovo Rangone 105
Bremen 103
Eugene 102
Venezia 101
Helsinki 100
Moscow 98
Napoli 94
Des Moines 92
San Diego 92
Turin 92
Munich 88
Ho Chi Minh City 86
Pisa 81
Shanghai 81
Palermo 77
Reggio Nell'emilia 77
Redwood City 76
Nuremberg 74
Bari 71
Mexico City 68
Trento 66
Naples 65
Buffalo 63
Elk Grove Village 58
Tampa 58
São Paulo 56
Trieste 56
Hanoi 53
Bolzano 50
Parma 50
Piemonte 50
Boardman 48
Falls Church 47
Jakarta 47
Udine 46
Oggiono 45
Monza 44
Vienna 43
Norwalk 41
Genoa 40
Messina 39
Tokyo 36
Nanjing 35
Pavia 35
Brussels 33
Dublin 33
Rio Saliceto 33
Cagliari 32
Columbus 32
Mountain View 32
Atlanta 31
Stockholm 31
Frankfurt am Main 30
Reggio Emilia 30
Kent 28
Prato 28
Dolo 27
Phoenix 27
Warsaw 27
Totale 21.370
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.216
Yessotoxin inhibits phagocytic activity of macrophages. 420
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 414
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 396
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 395
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 381
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 368
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 367
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 359
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 354
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 343
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 338
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 332
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 330
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 327
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 326
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 317
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 317
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 302
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 299
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 289
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 283
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 279
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 279
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 276
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 271
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 270
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 270
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 266
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 266
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 262
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 259
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 256
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 251
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 250
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 248
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 247
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 240
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 238
New strategies for the prevention and treatment of Helicobacter pylori infection 238
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 238
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 236
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 235
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 234
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 232
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 228
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 224
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 223
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 222
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 220
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 219
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 218
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 216
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 216
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 216
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 212
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 210
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 210
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 209
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 209
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 208
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 206
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 206
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 203
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 199
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 197
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 196
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 195
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 195
Physicochemical characterisation of the pertussis vaccine. 194
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 194
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 191
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 191
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 189
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 188
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 186
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 186
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 186
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 183
Interaction of pneumococcal surface structures with microglia 181
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 180
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 178
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 176
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 173
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 172
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 169
Bordetella 168
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 168
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 167
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 167
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 159
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 158
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 158
Brucella 155
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 154
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 153
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 147
The polisaccharyde capsule is necessary for the development of fatal pneumococcal meningitis in mice 144
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 142
Haemophilus 135
Totale 38.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.753 0 0 0 0 0 0 271 333 214 390 301 244
2021/20222.991 187 281 219 250 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/20266.500 620 472 686 1.584 2.161 656 321 0 0 0 0 0
Totale 40.619